Tudor Investment Corp
CLPT icon

Tudor Investment Corp’s ClearPoint Neuro CLPT Stock Holding History

Tudor Investment Corp’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
+156,971
New +$1.98M ﹤0.01% 2108
2025
Q3 		– Sell
-24,317
Closed -$290K – 3420
2025
Q2 		$290K Sell
24,317
-104,381
-81% -$1.31M ﹤0.01% 2906
2025
Q1 		$1.53M Buy
+128,698
New +$2M 0.01% 1526

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Tudor Investment Corp's CLPT Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 156,971 shares worth $1.43M. The stake represents ﹤0.01% of the portfolio and ranks #2108 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in CLPT as recently as Q2 2025.

Tudor Investment Corp first reported a position in CLPT in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.53M in Q1 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Tudor Investment Corp held 156,971 shares of ClearPoint Neuro worth $1.43M as of Q1 2026.
  • ClearPoint Neuro was a new Tudor Investment Corp position in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2108 holding.
  • Tudor Investment Corp first reported a position in ClearPoint Neuro in Q1 2025 and has held it in 3 quarters since.
  • Tudor Investment Corp's ClearPoint Neuro position peaked at $1.53M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.